Trial intelligence / Profile preview

Ability of Pupillometry to Reduce Sufentanil Consumption in Planned Cardiac Surgery

NCT03864016Completed

Sponsor
Centre Hospitalier Universitaire Dijon Bourgogne
Start
Mar 2019
Primary completion
Oct 2019
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised trial of sufentanil in pain (2 arms), sponsored by Centre Hospitalier Universitaire Dijon Bourgogne. Primary endpoint: Total dose of sufentanil required per operation. Started Mar 2019; status: completed.

02

Drugs

sufentanil
03

Conditions

pain

Beyond the preview

Go deeper on NCT03864016.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03864016.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call